Skip to Content

462 125 mg (Emend 125 mg)

Generic Name: aprepitant

Pill with imprint 462 125 mg is Pink & White, Capsule-shape and has been identified as Emend 125 mg. It is supplied by Merck & Company Inc..

Emend is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative and belongs to the drug class NK1 receptor antagonists. There is no proven risk in humans during pregnancy. Emend 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 462 125 mg

Emend

Generic Name:
aprepitant
Imprint:
462 125 mg
Strength:
125 mg
Color:
Pink & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
NK1 receptor antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Merck & Company Inc.
Inactive Ingredients:
sucrose
microcrystalline cellulose
hydroxypropyl cellulose (type h)
sodium lauryl sulfate
gelatin
titanium dioxide
silicon dioxide
ferric oxide red
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide